BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1922882)

  • 1. Prognostic scoring systems in differentiated thyroid carcinoma: which is the best?
    Kingma G; van den Bergen HA; de Vries JE
    Neth J Surg; 1991 Jun; 43(3):63-6. PubMed ID: 1922882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
    Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
    Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
    Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
    Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
    Lundgren CI; Hall P; Dickman PW; Zedenius J
    Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
    Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
    Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advanced age and clinical staging in the prognostic evaluation of differentiated carcinoma of the thyroid gland].
    Ardito G; Campanile FC; Furgiuele S; Diodati A; Di Giovanni V
    Minerva Chir; 1989 Mar; 44(6):995-8. PubMed ID: 2733846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The value of quantitative DNA analysis in evaluating the prognosis of differentiated thyroid cancer].
    Böttger T; Potratz D; Schernus B; Klupp J; Stöckle M; Junginger T
    Chirurg; 1994 Mar; 65(3):190-3. PubMed ID: 8194403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of insular versus papillary/follicular thyroid carcinoma.
    Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E
    Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with differentiated thyroid carcinoma.
    Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
    Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification and validation of prognostic factors in differentiated thyroid carcinoma].
    Gómez Arnaiz N; Gómez Sáez IM; Sahún de la Vega M; Abós R; Villabona Artero C; Soler Ramón J
    Med Clin (Barc); 1997 Jan; 108(2):45-9. PubMed ID: 9064416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of tumour size in papillary and follicular thyroid cancer.
    Passler C; Scheuba C; Asari R; Kaczirek K; Kaserer K; Niederle B
    Br J Surg; 2005 Feb; 92(2):184-9. PubMed ID: 15685703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
    Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
    Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of papillary thyroid carcinoma: uni- and multivariate analysis of prognostic factors (TNM staging system included).
    Pelizzo MR; Toniato A; Grigoletto R
    J Exp Clin Cancer Res; 1997 Sep; 16(3):261-5. PubMed ID: 9387899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.